NewAmsterdam Pharma Company
NAMS
#4245
Rank
NZ$3.48 B
Marketcap
$37.69
Share price
3.95%
Change (1 day)
119.33%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$98.63 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are NZ$98.63 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$92.82 M13.45%
2022-12-31NZ$81.82 M336.27%
2021-12-31NZ$18.75 M-30.16%
2020-12-31NZ$26.85 M